Loading company…
TetraLogic Pharmaceuticals develops therapies for cancer and other serious diseases.
TetraLogic Pharmaceuticals researches and develops therapeutic candidates for cancer and other serious diseases. Founded in 2001, it is based in Malvern, US, and is at Series C. Its December 2013 IPO raised USD 50 mn through the sale of 7.2 million shares at USD 7 each.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in